Showing results (31-40 of 1,188) with videos related to

Sort By:
Pageof 119
BMC Pharmacology & Toxicology|January 5, 2022
Assessment of NSAIDs as potential inhibitors of the fatty acid amide hydrolase I (FAAH-1) using three different primary fatty acid amide substrates in vitroJulius T Dongdem, Gideon K Helegbe, Kwame Opare-Asamoah, et al.
BMC Pharmacology & Toxicology|October 20, 2022
Real life evaluation of the multi-organ effects of Lumacaftor/Ivacaftor on F508del homozygous cystic fibrosis patientsKarin Yaacoby-Bianu, Zeev Schnapp, Ilana Koren, et al.
BMC Pharmacology & Toxicology|September 30, 2022
Accidental lead in contaminated pipe-borne water and dietary furan intake perturbs rats' hepatorenal function altering oxidative, inflammatory, and apoptotic balanceSolomon E Owumi, Uche O Arunsi, Omolola M Oyewumi, et al.
BMC Pharmacology & Toxicology|September 29, 2022
Resveratrol promotes liver cell survival in mice liver-induced ischemia-reperfusion through unfolded protein response: a possible approach in liver transplantationHamidreza Totonchi, Pooneh Mokarram, Saeed Karima, et al.
BMC Pharmacology & Toxicology|September 26, 2022
Demographic, clinical, and laboratory findings of mushroom-poisoned patients in Kermanshah province, west of IranMaryam Janatolmakan, Mohammad Rouhi Ganji, Touraj Ahmadi-Jouybari, et al.
BMC Pharmacology & Toxicology|September 27, 2022
Granisetron-mediated augmentation of sertraline therapeutic effect in obsessive-compulsive disorder: a double-blind placebo-controlled, randomized clinical trialAla Ghobadian, Saba Mokhtari, Behnam Shariati, et al.
BMC Pharmacology & Toxicology|September 27, 2015
Prevalence and predictors of prior antibacterial use among patients presenting to hospitals in Northern UgandaMoses Ocan, Yukari C Manabe, Hannington Baluku, et al.
BMC Pharmacology & Toxicology|November 22, 2015
Trientine induced colitis during therapy for Wilson disease: a case report and review of the literatureSalih Boga, Dhanpat Jain, Michael L Schilsky
BMC Pharmacology & Toxicology|September 13, 2015
Does antihypertensive treatment with renin-angiotensin system inhibitors prevent the development of diabetic kidney disease?Hiroki Miyazaki, Akira Babazono, Takumi Nishi, et al.
BMC Pharmacology & Toxicology|October 28, 2015
A novel nasal powder formulation of glucagon: toxicology studies in animal modelsFrederick E Reno, Patrick Normand, Kevin McInally, et al.
Pageof 119